Summit Therapeutics Inc vs Union Pacific Corporation — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Union Pacific Corporation trades at $295.68 (market cap $175.89B). The key difference: Union Pacific Corporation is far larger — about 16.8× Summit Therapeutics Inc's market cap, and Union Pacific Corporation pays a 1.86% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | UNP | |
|---|---|---|
Market Cap | $10.48B | $175.89B |
Sector | Health | Industrials |
52-Week High | $29.32 | $301.75 |
52-Week Low | $13.05 | $214.91 |
Enterprise Value | $9.90B | $206.36B |
Dividend Yield | — | 1.86% |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →